Skip to main content

Experience of the out-patient use of memotropil in the treatment of cognitive disorders in patients with chronic progressive cerebrovascular disorders

This is a preview of subscription content, access via your institution.

References

  1. 1.

    N. V. Vereshchagin and N. V. Lebedeva, “Mild forms of multi-infarct dementia: the efficacy of cerebrolysin,” Sov. Med., 11, 6–8 (1991).

    PubMed  Google Scholar 

  2. 2.

    S. I. Gavrilova, “Alzheimer's disease: contemporary approaches to diagnosis and treatment,” Zh. Farmakol. Ter., 11, No. 4, 88–96 (2002).

    Google Scholar 

  3. 3.

    I. V. Damulin, Dyscirculatory Encephalopathy in the Elderly and Aged [in Russian], Author's Abstract of Doctoral Thesis in Medical Sciences, Moscow (1997).

  4. 4.

    I. V. Damulin, “Vascular dementia,” Nevrol. Zh., 3, No. 4, 4–11 (1999).

    Google Scholar 

  5. 5.

    I. V. Damulin, N. A. Oryshich, and E. A. Ivanova, “Normotensive hydrocephalus,” Nevrol. Zh., 4, No. 6, 51–56 (1999).

    Google Scholar 

  6. 6.

    V. V. Zakharov, I. V. Damulin, and N. N. Yakhno, “The drug therapy of dementia,” Klin. Farmakol. Ter., 3, No. 4, 69–75 (1994).

    Google Scholar 

  7. 7.

    O. S. Levin and I. V. Damulin, “Diffuse changes in the white matter (leukoareosis) and the question of vascular dementia,” in: Progress in Neurogeriatrics [in Russian], N. N. Yakhno and I. V. Damulin (eds.) Moscow (1995), Vol. 2, pp. 199–231.

  8. 8.

    A. V. Medvedev, “Vascular dementia,” Sov. Psikhiat., 4, 20–24 (1998).

    Google Scholar 

  9. 9.

    I. V. Shcherbakova, T. P. Klyushnik, S. A. Ermakova, et al., “Interaction between inflammatory and autoimmune factors in ischemic stroke,” Zh. Nevrol. Psikhiat., 4 (2001).

  10. 10.

    N. N. Yakhno and V. V. Zakharov, “Memory impairments in neurological practice,” Nevrol. Zh., 4, 4–9 (1997).

    Google Scholar 

  11. 11.

    G. McKhann, D. Drachman, D. Folstein, et al., “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease,” Neurology, 146, 939–944 (1984).

    Google Scholar 

  12. 12.

    R. Mielke, K. Herholz, M. Grond, et al., “Severity of vascular dementia is related to volume of metabolically impaired tissue,” Arch. Neurol., 49, No. 9, 909–913 (1992).

    PubMed  CAS  Google Scholar 

  13. 13.

    R. Tien, “The Dementias: correlation of clinical features, pathophysiology, and neuroradiology, ” AJR, 161, 245–255 (1993).

    PubMed  CAS  Google Scholar 

  14. 14.

    B. Winbald and N. Poritis, Memantine in Severe Dementia: Results of the M-BEST Trial (Basis of Treatment of Patients with Severe Depression) [in Russian] (1998).

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to T. T. Batysheva.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 108, No. 1, pp. 40–44, January, 2008.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Batysheva, T.T., Bagir’, L.V., Kostenko, E.V. et al. Experience of the out-patient use of memotropil in the treatment of cognitive disorders in patients with chronic progressive cerebrovascular disorders. Neurosci Behav Physi 39, 193–197 (2009). https://doi.org/10.1007/s11055-009-9109-7

Download citation

Keywords

  • Dementia
  • Mild Cognitive Impairment
  • Chronic Fatigue Syndrome
  • Memantine
  • Vascular Dementia